Furthermore, high Pgrn expression levels as detected in the tumor itself or in the peripheral blood have been linked to an aggressive phenotype and poor prognosis in breast cancer [17], glioblastoma [16] and ovarian cancer [18]. Here, GRN is linked to ovarian carcinoma.